Dermal Filler Global Market Report 2024

The dermal filler market size has grown rapidly in recent years. It will grow from $6.07 billion in 2023 to $6.74 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historical period can be attributed to the expansion of the aesthetic industry, notable advancements in injection techniques, the influential endorsements and impact of celebrities, a growing focus on anti-aging solutions, and an increase in minimally invasive procedures within the industry.

The dermal filler market size is expected to see rapid growth in the next few years. It will grow to $10.1 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The anticipated growth in the forecast period is expected due to market expansion in emerging economies, the trend toward customized and personalized treatments, the development of biodegradable and bioresorbable fillers, and a strong focus on achieving longevity and durability in aesthetic procedures.

The rise in aesthetic procedures by plastic surgeons drives the dermal filler market. As more individuals seek aesthetic enhancements, the demand for dermal fillers in plastic surgeries increases. The American Society for Aesthetic Plastic Surgery reported a significant rise in facial and body procedures in 2021.

The rise in the aging population is set to propel growth within the dermal filler market. ReliefWeb's insights in July 2022 suggest a substantial rise in the proportion of individuals aged 65 and older by 2050. This demographic change fuels the demand for dermal fillers among the aging population.

The dermal filler market thrives on technological advancements, exemplified by Sinclair Pharma's launch of MaiLi in April 2021. Utilizing OxiFree HA technology, this hyaluronic acid filler offers efficacy with 24% less product usage. For instance, in April 2021, Sinclair Pharma, a UK-based pharmaceutical company, launched MaiLi, a new hyaluronic acid filler that harnesses the power of OxiFree HA technology for the treatment of medium-sized skin depressions, fine-lines, the periorbital area, and is effective for lip enhancement. MaiLi uses 24% less product for the same volumizing effect.

Prominent companies operating in the dermal filler market are developing innovative products such as lip augmentation fillers to enhance product offerings and gain a competitive advantage. Lip augmentation fillers are employed to change the size and form of the lips, usually by injecting fillers such as hyaluronic acid or collagen. Allergan Aesthetics received FDA approval in February 2022 for JUVÉDERM VOLBELLA XC for infraorbital hollow treatment, expanding its product offering and launching a comprehensive training program for clinicians.

In October 2022, Prollenium Medical Technologies, a Canada-based medical technology company that manufactures dermal fillers, acquired SoftFil for an undisclosed amount. Both firms are dedicated to increasing the safety and efficacy of cosmetic medical operations. The shared objective of the SoftFil and Revanesse brands was a deciding factor in this transaction. The goal of Prollenium's purchase is to maintain the SoftFil brand's independence and character while also strengthening its international presence via the development of creative interconnections between both brands, SoftFil and Revanesse. SoftFil is a France-based company that manufactures dermal fillers, micro-cannulas, and innovative cosmetics.


Major companies operating in the dermal filler market report are Allergan Inc., Sanofi Aventis, Merz Pharma GmbH & Co. KGaA, Laboratoires Vivacy, Bloomage Biotechnology Corporation Limited, LG Life Sciences, Polymekon, Tiffen Medical, Shanghai Haohai Biological Technology Co. Ltd., Teoxane Laboratories, Sinclair Pharma, Anika Therapeutics Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., Mentor Worldwide LLC, BioPlus Co. Ltd., Hans Biomed Corp., Regen Lab SA, Prollenium Medical Technologies Inc., Scivision Biotech Inc., Hyaltech Ltd., Dr. Korman Laboratories Ltd., Bioxis Pharmaceuticals, Suneva Medical Inc., Bohus BioTech AB, Medy Tox Inc., Galderma S.A., Sculpt Fillers, Sylagen, Matex Lab SA, Galatea Surgical.

North America was the largest region in the dermal filler market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermal filler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dermal filler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Dermal fillers come in various types such as calcium hydroxylapatite, hyaluronic acid, poly-alkylimide, polylactic acid, and polymethylmethacrylate microspheres. Calcium Hydroxylapatite fillers are particularly effective for addressing moderate-to-severe creases such as nasolabial folds, marionette lines, and frown lines, also enhancing cheek fullness and other facial contours. These fillers can be biodegradable or non-biodegradable and serve multiple applications including scar treatment, wrinkle correction, lip enhancement, and restoring facial volume. End users benefiting from these treatments include hospitals, cosmetic clinics, outpatient centers, beauty centers, and various other medical facilities offering cosmetic procedures.

The dermal fillers market research report is one of a series of new reports that provides dermal filler market statistics, including dermal filler industry global market size, regional shares, competitors with a dermal filler market share, detailed dermal filler market segments, market trends and opportunities, and any further data you may need to thrive in the dermal filler industry. This dermal filler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The dermal filler market consists of sales of autologous fat injections, permanent soft tissue filler. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.